-       Report 
   - November 2025
    -  196 Pages 
    Global
   
   From       €5258EUR$5,850USD£4,611GBP 
                -       Clinical Trials 
   - February 2025
    -  604 Pages 
    Global
   
   From       €3101EUR$3,450USD£2,720GBP 
                -       Clinical Trials 
   - November 2024
    -  893 Pages 
    Global
   
   From       €3101EUR$3,450USD£2,720GBP 
                  -       Report 
   - May 2024
    -  138 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                  -       Report 
   - May 2024
    -  132 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                   -       Report 
   - January 2022
    -  60 Pages 
    Global
   
   From       €2840EUR$3,160USD£2,491GBP 
      €3550EUR$3,950USD£3,114GBP 
                  -       Report 
   - June 2024
    -  200 Pages 
    Global
   
   From       €5716EUR$6,360USD£5,013GBP 
      €7146EUR$7,950USD£6,267GBP 
                -       Report 
   - November 2022
    -  79 Pages 
    Global
   
   From       €1798EUR$2,000USD£1,577GBP 
                -       Report 
   - May 2023
    -  528 Pages 
    Global
   
   From       €2247EUR$2,500USD£1,971GBP 
                -       Report 
   - July 2022
    -  27 Pages 
    Global
   
   From       €3591EUR$3,995USD£3,149GBP 
                -       Report 
   - August 2023
    -  85 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
             
         Macular Edema Drug is a type of drug used to treat macular edema, a condition in which fluid accumulates in the macula, the central part of the retina. This accumulation of fluid can cause vision loss and other vision problems. Macular Edema Drugs are used to reduce the swelling and improve vision. These drugs can be administered orally, intravenously, or intravitreally. Commonly used Macular Edema Drugs include corticosteroids, anti-VEGF agents, and non-steroidal anti-inflammatory drugs.
Macular    Edema Drugs are part of the larger Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions, such as glaucoma, cataracts, and age-related macular degeneration. These drugs are used to improve vision, reduce pain, and slow the progression of the disease.
Some companies in the Macular Edema Drug market include Allergan, Regeneron, Novartis, and Roche. Show Less   Read more